Psilocybin, the active psychedelic ingredient in magic mushrooms, has been proven to impact patients with depression positively. Vail Health’s OPTIMIZE study, which will administer doses of psilocybin ...

A new investigation published in the journal Neuropharmacology offers a nuanced perspective on the popular practice of ...

“Shrooms,” also known as magic mushrooms, are a popular hallucinogenic drug that has been used recreationally for centuries across the globe. And in recent years, some research has shown potential ...

Psilocybin—the psychedelic compound that occurs naturally in certain "magic" mushroom species—has been shown in trials to provide long-term treatment for depression and anxiety. But the chemical's ...

A study, published in Molecular Psychiatry, led by Prof. Bernard Lerer from the Department of Psychiatry at the Hadassah—Hebrew University Medical Center shows promising results for using psilocybin, ...

Researchers have developed a new model to study the antidepressant and anti-anxiety effects of psilocybin in mice.

Participants received a single dose of either 25 mg of COMP360 or placebo On track for disclosure of top-line 6-week primary endpoint results in late June “Completing dosing of all participants in ...

A new clinical trial suggests that a single dose of psilocybin, combined with mindfulness training, may offer short-term relief from depression and burnout for frontline healthcare workers. Published ...

Psilocybin therapy reduced depression symptoms in clinicians who developed these symptoms after frontline clinical work during the COVID-19 pandemic, a small randomized trial showed. At day 28, the ...